Personalized Medicine

Papers
(The median citation count of Personalized Medicine is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Microsatellite Instability Testing in Colorectal Patients with Lynch Syndrome: Lessons Learned from a Case Report and How to Avoid Such Pitfalls39
The Evolution of Personalized Healthcare and the Pivotal Role of European Regions in its Implementation34
The United States 2020 Census Data: Implications for Precision Medicine and the Research Landscape20
Elevated Expression of ASF1B Correlates with Poor Prognosis in Human Lung Adenocarcinoma18
Pharmacogenomic Considerations for Repurposing of Dexamethasone as a Potential Drug Against SARS-CoV-2 Infection15
Gout Prevalence in the Hmong: A Prime Example of Health Disparity and the Role of Community-Based Genetic Research13
Artificial Intelligence in Healthcare: a Primer for Medical Education in Radiomics13
Genetic and genomic learning needs of oncologists and oncology nurses in the era of precision medicine: a scoping review12
MiR-452-5p Mediates the Proliferation, Migration and Invasion of Hepatocellular Carcinoma Cells Via Targeting COLEC1011
Creating Accessible Spanish Language Materials for Clinical Sequencing Evidence-Generating Research Consortium Genomic Projects: Challenges and Lessons Learned10
Clinician Perspectives on Communication and Implementation Challenges in Precision Oncology10
The Frequency of Major CYP2C19 Genetic Polymorphisms in Women of Asian, Native Hawaiian and Pacific Islander Subgroups10
Mini-Gut Feelings: Perspectives of People with Cystic Fibrosis on the Ethics and Governance of Organoid Biobanking9
miR-516a-3P, a Potential Circulating Biomarker in Hepatocellular Carcinoma, Correlated with rs738409 Polymorphism in PNPLA39
Recommendations to Researchers for Aiding in Increasing American Indian Representation in Genetic Research and Personalized Medicine9
LncRNA ZFAS1, as a Poor Prognostic Indicator, Promotes Cell Proliferation and Epithelial–Mesenchymal Transition in Endometrial Carcinoma9
Stem Cells as Therapeutic Targets in Colorectal Cancer9
Intelligent Health System for the Investigation of Consenting COVID-19 Patients and Precision Medicine8
Concentration and Integrity Indexes of Urine Cell-Free DNA as Promising Biomarkers for Early Lung Cancer Diagnosis7
MiR-455-5p Serves as a Biomarker of Atherosclerosis and Inhibits Vascular Smooth Muscle Cell Proliferation and Migration6
Expanded Carrier Screening in Flanders (Belgium): An Online Survey on the Perspectives of Nonpregnant Reproductive-Aged Women6
Family-Level Impact of Genetic Testing: Integrating Health Economics and Ethical, Legal, and Social Implications6
Targeting Molecular Alterations in Non-Small-Cell Lung Cancer: What’s Next?6
Clinical Significance of Serum miR-101-3p Expression in Patients with Neonatal Sepsis6
Correlation of miR-600 with WT1 Expression and its Potential Clinical Significance in Breast Cancer6
The Role of miR-101 in Esophageal and Gastric Cancer6
Healthcare Professionals’ Knowledge, Attitudes and Future Expectations Towards Personalized Medicine6
An International Genomics Health Workforce Education Priorities Assessment6
The interplay between pharmacogenetics, concomitant drugs and blood levels of amitriptyline and its main metabolites5
Sino-European Science and Technology Collaboration on Personalized Medicine: Overview, Trends and Future Perspectives5
Exploring the usefulness of plasma level determination and pharmacogenetics for patients treated with clozapine5
Guanylyl Cyclase C as a Diagnostic and Therapeutic Target in Colorectal Cancer5
Views on Genomic Research Result Delivery Methods and Informed Consent: A Review5
Cost–effectiveness of Genetic-Based Screening Strategies for Maturity-Onset Diabetes of the Young5
Alignment of health plan coverage policies for somatic multigene panel testing with clinical guidelines in select solid tumors5
Prioritizing Pharmacogenomics Implementation Initiatives: A Survey of Healthcare Professionals5
Defining the Role of Pharmacists in Medication-Related Genetic Counseling5
Attitudes of Costa Rican Individuals Towards Donation of Personal Genetic Data for Research5
SKA3 , negatively regulated by miR-128-3p , promotes the progression of non-small-cell lung cancer4
Recent Advances in Personalized Cancer Immunotherapy with Immune Checkpoint Inhibitors, T Cells and Vaccines4
Genetic Predisposition for the Development of Lamotrigine-Induced Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis: a Systematic Review and Meta-Analysis4
Role of precision nutrition in improving military performance4
Association of PON-1 polymorphism with susceptibility to and severity of ischemic stroke in the Chinese population4
Personalized Therapy: Can it Tame the COVID-19 Monster?4
Budget Impact and Transferability of Cost–effectiveness of DPYD Testing in Metastatic Breast Cancer in Three Health Systems4
Long Noncoding RNA Polymorphisms and Hepatocellular Carcinoma and Pancreatic Cancer Risk4
The Integration of Personalized Medicine Into Health Systems: Progress and a Path Forward4
PON1 Polymorphisms Can Predict Generalized Anxiety and Depressed Mood in Patients with Multiple Chemical Sensitivity4
How can we address the uncertainties regarding the potential clinical utility of polygenic score-based tests?4
Association Study of Genetic Polymorphisms in GABRD with Treatment Response and Dose in Methadone Maintenance Treatment4
Application of Transcriptomics and Proteomics in Pulmonary Arterial Hypertension4
Sars-Cov-2 Variant Identification Using a Genome Tiling Array and Genotyping Probes3
The Role of Metabolomics in Personalized Medicine for Diabetes3
A GRIN3A Polymorphism may be Associated with Glucocorticoid-Induced Symptomatic Osteonecrosis in Children with Acute Lymphoblastic Leukemia3
Medical geneticists, genetic diseases and services in Brazil in the age of personalized medicine3
Deliberations About Clinical Pharmacogenetic Testing in Pediatric Oncology3
HER2 in Gastric Adenocarcinoma: Where Do we Stand Today?3
Omics Technologies in Personalized Combination Therapy for Cardiovascular Diseases: Challenges and Opportunities3
RNA-Based Next-Generation Sequencing in Non-Small-Cell Lung Cancer in a Routine Setting: an Experience from an Italian Referral Center3
miR-938 rs2505901 T>C Polymorphism Increases Hirschsprung Disease Risk: A Case–Control Study of Chinese Children3
Cost–effectiveness of extended DPYD testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK3
LncRNA Polymorphisms and Lung Cancer Risk3
Investigation of DPYD , MTHFR and TYMS Polymorphisms on 5-Fluorouracil Related Toxicities in Colorectal Can3
Polymorphisms in Genes Involved in Breast Cancer Among Iranian Patients3
A Visfatin Gene Promoter Polymorphism (Rs1319501) is Associated With Susceptibility to Nonalcoholic Fatty Liver Disease3
Racial and Ethnic Minority Patient Participation in N-of-1 Trials: Perspectives of Healthcare Providers and Patients2
Patient views on genetics and functional imaging for precision medicine: a willingness-to-pay analysis2
Investigating underlying human immunity genes, implicated diseases and their relationship to COVID-192
State-of-the-art knowledge on the regulation of advanced therapy medicinal products2
Long Noncoding RNA Polymorphisms in Gynecological Cancers2
The Pharmacogenetics of Mycophenolate Mofetil in Tunisian Renal Transplant Patients2
Nanosensor Technologies and the Digital Transformation of Healthcare2
Pharmacogenomics of Lipid-Lowering Agents: the Impact on Efficacy and Safety2
Cost–effectiveness of Alternative NTRK Testing Strategies in Cancer Patients Followed by Histology-Independent Therapy with Entrectinib: an Analysis of Three European Co2
Preferences for pharmacogenomic testing in polypharmacy patients: a discrete choice experiment2
Financial incentives to promote personalized medicine in Europe: an overview and guidance for implementation2
Personalized Medicine in Lipid-Modifying Therapy2
Developing and Validating Noninvasive Prenatal Testing for de novo Autosomal Dominant Monogenic Diseases in Vietnam2
ABCB1 and SLCO1B1  Gene Polymorphisms Predict Methotrexate-Resistant for Low-Risk Gestational Trophoblastic Neoplasia2
miR-369-3p Serves as Prognostic Factor and Regulates Cancer Progression of Hepatocellular Carcinoma2
Pharmacogenomic Testing for Mental Health (Part I): Documenting Early Adopter Perceptions of Use for Eight Scenarios2
Attitudes toward pharmacogenetics in patients undergoing CYP2C19 testing following percutaneous coronary intervention2
Correlation Between Plasma lncRNA CASC11 and Malignancy in Lung Adenocarcinoma Patients and the Prognostic Value of lncRNA CASC112
Development and evaluation of an exome sequencing training course for medical interpreters2
Therapeutic Drug Monitoring Guided Fluconazole Therapy in a Patient with Cholangitis Sepsis2
Association of NQO1Pro187Ser Polymorphism with Clinical Outcomes and Survival of Lung Cancer Patients Treated with Platinum Chemotherapy2
HEcoPerMed, Personalized Medicine from a Health Economic Perspective: Lessons Learned and Potential Opportunities Ahead2
Development of Competency-based Online Genomic Medicine Training (COGENT)2
Cost–effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries2
Pathology-Supported Genetic Testing Presents Opportunities for Improved Disability Outcomes in Multiple Sclerosis2
Ethics and Equity in Rare Disease Research and Healthcare1
Somatic Mitochondrial DNA Mutations in Different Grades of Glioma1
Blood direct PCR: impact of CYP2C19 and CYP4F2 variants for bleeding prediction in ST-elevation myocardial infarction patients with ticagr1
CYP1A1 Common Gene Polymorphisms and Ischemic Stroke Risk: a Meta-Analysis and a Structural Examination1
A Precision Medicine Approach to Stress Testing Using Metabolomics and Microribonucleic Acids1
COVID-19 Telehealth Preparedness: a Cross-Sectional Assessment of Cardiology Practices in the USA1
Machine-Learning Models Utilizing Cyp3A4*1G Show Improved Prediction of Hypoglycemic Medication in Type 2 Diabetes1
A Personalized Approach to Pancreatic Ductal Adenocarcinoma and its Application in Surgical Practice1
Aminoglycosides’ Dosage in Hematological Malignancies and Febrile Neutropenia: Extended Interval or Conventional Dosage?1
Seven non-Differentially Expressed ‘Dark Biomarkers’ Show Transcriptional Dysregulation in Chronic Lymphocytic Leukemia1
Personalized Medicine, the Inevitable Future of Cancer Immunotherapy1
Lessons Learned from the Application of the HEcoPerMed Guidance to Three Modeling Case Studies1
BRAF: a biomarker not to be missed in glioblastoma1
Helping patients understand multi-cancer early detection tests: a scoping review1
Impact of CYP2C9*2 and *3 Polymorphisms on Valproate-Associated Adverse Drug Reactions in Individuals living with Epilepsy: a Case–control1
Incidence of statin-associated muscle symptoms in patients taking statins with RYR1 or CACNA1S variants1
Anna Karenina Principle in Personalized Treatment of Bladder Cancer According to Oncogram: Which Drug for which Patient?1
Texas Health Educators’ Practice in Basic Genomics Education and Services1
Avoiding “Toxic Knowledge”: the Importance of Framing Personalized Risk Information in Clinical Decision-Making1
Research and Innovation in Personalized Medicine: a Descriptive Synthesis of Actors in the EU and China1
A novel TGFβR2 splice variant in patient with aortic aneurysm and family history for aortic dissection: a case report1
Biomarker Testing in Patients Diagnosed With Advanced/Metastatic Medullary Thyroid Cancer in the USA1
Challenges and Opportunities in Building a Health Economic Framework for Personalized Medicine in Oncology1
The Use of Molecular Biomarker Tests: An Interview Study with Healthcare Providers about a Molecular Biomarker Test for Prostate Cancer1
Developing New Frameworks to Value Genomic Information: Accounting for Complexity1
Biomarker-Driven Immunotherapy for Precision Medicine in Prostate Cancer1
A Sociogenomic Paradigm to Replace the Racial Paradigm1
0.03817892074585